Biofrontera AG Sustainability Reports

Biofrontera AG is a biopharmaceutical company specializing in the development and commercialization of dermatological drugs and medical cosmetics, with a primary focus on photodynamic therapy products for skin diseases.

Sector: Manufacturing

Country: Germany

Exchange: Deutsche Börse (Xetra)

LEI: 391200D6GFSVFGFQTL13

FIGI: BBG001SHW0J3

28 reports from 2013 to 2025

• Biofrontera AG 2025 Declaration of Conformity
• Biofrontera AG 2025 Corporate Governance Declaration
• Biofrontera AG 2025 Annual Report
• Biofrontera AG 2025 Combined Management Report and Group Management Report
• Biofrontera AG 2024 Declaration on Corporate Governance